CHRS Coherus BioSciences, Inc.

NASDAQ
$1.42

Coherus BioSciences, Inc. (CHRS) SEC Filings

Everything CHRS has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

23 filings
Date Form Filing
8-K REG_FD
8-K OTHER_EVENT
8-K OTHER_REG_FD
8-K OTHER
8-K MATERIAL_AGREEMENT
8-K MATERIAL_AGREEMENT
8-K CAPITAL_RAISE
8-K MATERIAL_AGREEMENT
8-K AGREEMENT_TERMINATED
8-K DEBT
4
4
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.